B. Braun pricing H.E.L.P. LDL cholesterol reduction system competitively with Kaneka's Liposorber.
This article was originally published in The Gray Sheet
B. BRAUN MEDICAL H.E.L.P. LDL CHOLESTEROL REDUCTION SYSTEM will be priced competitively with Kaneka's Liposorber LA-15, the company says. The heparin-induced extracorporeal lipoprotein precipitation system, approved by FDA on Sept. 19, is the second device to gain approval for the reduction of low-density lipoprotein cholesterol in patients not responding to diet and drug therapies.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.